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Abstract
Background: To compare the effects of low versus recommended levels of dairy intake on weight maintenance
and body composition subsequent to weight loss.
Design and Methods: Two site (University of Kansas-KU; University of Tennessee-UT), 9 month, randomized
trial. Weight loss was baseline to 3 months, weight maintenance was 4 to 9 months. Participants were maintained
randomly assigned to low dairy (< 1 dairy serving/d) or recommended dairy (> 3 servings/d) diets for the
maintenance phase. Three hundred thirty eight men and women, age: 40.3 ± 7.0 years and BMI: 34.5 ± 3.1, were
randomized; Change in weight and body composition (total fat, trunk fat) from 4 to 9 months were the primary
outcomes. Blood chemistry, blood pressure, resting metabolism, and respiratory quotient were secondary
outcomes. Energy intake, calcium intake, dairy intake, and physical activity were measured as process evaluation.
Results:  During weight maintenance, there were no overall significant differences for weight or body
composition between the low and recommended dairy groups. A significant site interaction occurred with the
low dairy group at KU maintaining weight and body composition and the low dairy group at UT increasing weight
and body fat. The recommended dairy group exhibited reductions in plasma 1,25-(OH)2-D while no change was
observed in the low dairy group. No other differences were found for blood chemistry, blood pressure or physical
activity between low and recommended dairy groups. The recommended dairy group showed significantly greater
energy intake and lower respiratory quotient compared to the low dairy group.
Conclusion: Weight maintenance was similar for low and recommended dairy groups. The recommended dairy
group exhibited evidence of greater fat oxidation and was able to consume greater energy without greater weight
gain compared to the low dairy group. Recommended levels of dairy products may be used during weight
maintenance without contributing to weight gain compared to diets low in dairy products.
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Background
Almost two thirds of US adults are overweight or obese [1]
and at any given time 50% are attempting to control their
weight [2]. Dietary calcium appears to play a role in the
regulation of energy metabolism [3], and data from sev-
eral studies support an "anti-obesity" effect of dietary cal-
cium [3]. High calcium diets attenuate adipocyte lipid
accretion and weight gain during periods of over-con-
sumption of an energy-dense diet in a rodent model of
diet-induced obesity and increase lipolysis and preserve
thermogenesis during energy restriction in this model,
thereby increasing the loss of body weight and fat [4].
Notably, dairy sources of calcium exerted significantly
greater effects in both attenuating weight and fat gain dur-
ing over-feeding and accelerating weight and fat loss dur-
ing energy restriction in rodents [3,4].
Recent clinical studies are consistent with these observa-
tions. Increasing dietary calcium intake from ~400 to
~1200 mg/day during constant energy restriction (-500
kcal/day) resulted in 26 and 28% increases in weight and
fat loss, respectively, compared to the lower calcium
intake over a 24-week period, while significantly (~2-fold)
greater effects were noted when dairy foods were utilized
as a calcium source [5]. Similarly, a shorter-term (12-
week) study demonstrated that incorporation of sufficient
yogurt into the daily diet to increase dietary calcium from
~500 to ~1100 mg/day without altering macronutrient
intake during energy restriction of -500 kcal/day aug-
mented fat loss by 61% compared to the low calcium
group [6]. A six month clinical trial utilizing a mixture of
dairy foods in obese African-American adults resulted in
essentially similar effects on weight and fat loss in the
presence of energy restriction [7]. However, a similar
increase in dairy intake for six months in the absence of
energy restriction did not alter body weight, but did result
in 5.4% and 4.6% reductions in body fat and trunk fat,
respectively, in obese African-Americans [7]. In contrast,
increasing the dairy product intake of subjects consuming
moderate levels of calcium (~800 mg/day) and dairy dur-
ing energy restriction did not alter weight loss in a 48-
week trial [8].
Retrospective, observational, and epidemiological
reports, including a two-year study of normal weight
women [9] and ten-year data from the CARDIA study [10]
support an inverse relationship between dairy intake and
adiposity. Further, recent data from the Women's Health
Initiative clinical trial [11] demonstrate a modest but con-
sistent significant attenuation of post-menopausal weight
gain after three and seven years of follow-up in the cal-
cium/vitamin D-supplemented group compared to the
placebo group. Notably, results of this large randomized
double-blinded placebo-controlled trial comparing the
effects of 1000 mg calcium plus 400 IU vitamin D/day in
36,282 post-menopausal women (18,176 active treat-
ment and 18,106 placebo) demonstrated benefit only in
those whose baseline calcium intake was suboptimal, as
treatment effects were only seen in the women with base-
line calcium intakes less than 1200 mg/day. These find-
ings also are supported by several epidemiological
evaluations, including the Quebec Family Study [12], the
Heritage Family Study [13] and the Tehran Lipid and Glu-
cose study [14]. However, some secondary analyses [15]
and clinical trials [8,16,17] have failed to find this rela-
tionship.
Nonetheless, the role of dietary calcium in attenuating
adiposity is further supported by mechanistic data. The
increase in calcitriol (1,25-dihydroxyvitamin D) elicited
by low calcium diets modulates both lipogenesis and
lipolysis, thereby increasing lipid filling and adiposity
[3,18]; in addition, calcitriol suppresses adipocyte uncou-
pling protein 2 (UCP 2) expression and thereby reduces
UCP 2-mediated mitochondrial fatty acid transport and
oxidation [18,19] and adipocyte apoptosis [18]. Con-
versely, increasing dietary calcium from sub-optimal to
optimal levels suppresses calcitriol levels, thereby reduc-
ing the efficiency of adipocyte lipid storage [3,18].
Increasing dietary calcium also results in increased fecal
fatty acid excretion and energy loss which may also con-
tribute to calcium's effect on adiposity [20,21]. The addi-
tional bioactivity (i.e. non-calcium mediated) of dairy
foods has not been definitively identified, although the
high concentration of leucine and of angiotensin convert-
ing enzyme (ACE) inhibitors in dairy may contribute to
the additional effect [18,22].
Thus, multiple lines of evidence suggest a potentially
important role for dietary calcium and dairy foods in the
prevention and treatment of obesity. However, weight
maintenance following successful weight loss is a critical
component to the successful management of obesity, and
although there are animal data to support the concept of
calcium and dairy attenuation of weight and fat regain
[23], no clinical or population data are yet available
regarding the role of dairy foods in weight maintenance
following successful weight loss. Accordingly, this study
was performed to assess the effects of recommended ver-
sus low dairy diets on weight maintenance following a
weight loss program undertaken by overweight and obese
adults.
Methods
This was a 2 site investigation located at the University of
Kansas (KU) and The University of Tennessee (UT).
Weight loss was from baseline (0) to 3 months followed
by weight maintenance from 4 months to 9 months. To be
eligible for weight maintenance, participants had to
achieve the greater of a 10 kg or 10% weight loss fromNutrition & Metabolism 2008, 5:28 http://www.nutritionandmetabolism.com/content/5/1/28
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baseline. Participants who did not achieve this value were
referred to alternative weight management programs. The
primary outcomes were changes in weight and body com-
position during maintenance (4 months to 9 months).
Participants
Potential participants underwent initial eligibility screen-
ing by telephone. Participants were 19 to 65 years of age
and between 25 and 39.9 BMI. Participants were excluded
if they could not participate in moderately vigorous phys-
ical activity, used special diets (i.e. vegetarian), used med-
ications affecting metabolism (i.e. beta blockers, etc.), or
were currently taking calcium supplementation. Partici-
pants were excluded if they exhibited eating disorders
(score >20 on the Eating Attitudes Test) [24], restraint
(score of 11 or higher on the Eating Inventory Question-
naire) [25], depression (i.e., score >35 on the Center for
Epidemiological Studies Depression Scale) [26], or drug
addiction (medical history). In addition, participants
were excluded if they had any metabolic disease that
affected energy balance (e.g. diabetes mellitus or hypothy-
roidism). Participants were randomized to either recom-
mended dairy (= 3 servings/d) [27] or low dairy (= 1
serving/d) at baseline; however, the assignment was
blinded to both participant and staff for 0–3 months to
diminish any bias from group assignment during weight
loss. A summary of randomization and participation is
shown in Figure 1.
Weight management clinics
Weight management clinics were conducted weekly for
the entire investigation for ~60 minutes for both recom-
mended and low dairy groups. The same health educator
at each site led both recommended and low dairy groups
to diminish investigator bias. Groups met on separate
days to minimize contamination. Both groups received
the same behaviorally based clinic on topics of lifestyle
change, physical activity, and nutrition. For example, top-
ics included preparation of meals, shopping, label read-
ing, addition of fruits and vegetables (F/V), physical
activity (PA), goal-setting, self-monitoring, social support,
etc. Information differed only on the topic of nutrition
Participant flow through the study Figure 1
Participant flow through the study.Nutrition & Metabolism 2008, 5:28 http://www.nutritionandmetabolism.com/content/5/1/28
Page 4 of 13
(page number not for citation purposes)
during weight maintenance where the group randomized
to recommended dairy received information and strate-
gies for achieving = 3 servings of dairy per day and the
group randomized to low dairy did not receive this infor-
mation. At each meeting, participants reported the esti-
mated energy expended each week through PA as well as
the number of steps recorded by step counter. For quality
assurance, clinics were supervised by one of the investiga-
tors.
Weight loss diet (Months 1–3)
Energy intake was reduced to ~1,200 to 1,500 kcal/day
using a combination of meal plans, pre-packaged meals
(PMs), F/V, and shakes. A typical daily weight loss diet can
be found in Table 1. Non-caloric beverages such as water,
diet soda, coffee, etc. were allowed ad libitum. If partici-
pants reported hunger during the diet, they were encour-
aged to consume more F/V.
Table 1: Typical daily intake during weight loss phase
Breakfast
Smoothie made with vanilla shake <300 kcal 1 PM
1 cup berries and 1 banana 2 fruits
Mid-morning snack
Apple ≈ 70 kcal 1 fruit
Lunch
Vegetable Stew with Beef entrée <300 kcal 1 PM/diet plan meal
1 cup cooked bell peppers and 1 cup diced tomatoes 2 vegetables
Afternoon snack
Chocolate shake ≈ 100 kcal 1 PM
Dinner
3 oz grilled skinless chicken breast 1 medium baked potato <350 kcal 1 PM/diet plan meal
1 cup cooked broccoli 1 vegetable
1 bunch grapes 1/2 fruit
Late-night snack
Chocolate pudding ≈ 150 kcal 1 PM/diet plan snack
1/2 sliced banana 1/2 fruitNutrition & Metabolism 2008, 5:28 http://www.nutritionandmetabolism.com/content/5/1/28
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Weight maintenance diet (Months 4–9)
Participants consumed a weight maintenance diet using
healthy eating strategies learned during clinics (i.e., por-
tion control, record keeping, high-volume/low energy
foods). Maintenance levels of calorie intake were esti-
mated from predicted resting metabolic rate (RMR) and
level of reported physical activity. Participants were
encouraged to continue to use meal plans, PMs, 5 servings
of F/V, and non-caloric beverages of choice as part of their
weight maintenance strategy. Participants in the recom-
mended dairy group were instructed to consume at least 3
servings of dairy per day as fluid milk, yogurt, or cheese
and those in the low dairy group were instructed to con-
sume 1 or fewer servings of dairy per day. Dairy servings
were standardized at 1 cup (240 mL) milk, 1 cup (227 g)
yogurt or 42 g hard cheese (e.g. cheddar).
Moderately vigorous physical activity (MVPA)
A progressive program of MVPA (walking) was designed
to target ~10,000 steps per day by week 4. Participants
were given pedometers at baseline and reported steps at
weekly meetings. The number of steps per day was aver-
aged across 3 month intervals and recorded at 3, 6, and 9
months.
Energy and dairy intake
Three day food records were obtained at baseline, 3, 6,
and 9 months. The records were reviewed and clarified in
an interview with a registered dietitian utilizing food
models and neutral probing questions, as previously
described [5,28]. Subsequently, the food records were
coded and entered into a computer software system for
analysis of nutrient composition, energy intake, and serv-
ings of dairy products using the USDA National Nutrient
Data Base for Standard Reference http://www.ars.usda.
gov/nutrientdata.
Staff training and site coordination
Staff training occurred at each site according to mutually
approved protocols. Prior to data collection, all staff had
to be certified per procedure. For example, values for dual
energy X-ray absorptiometry (DEXA), food records, etc.,
were compared to known standards or to values generated
by the investigators. Adherence to protocols was moni-
tored by the site PI. All data collected from both sites were
transferred to a data coordinator at KU to check for accu-
racy, completeness, outliers, etc. Data were subsequently
transferred to the study statistician (MM) for analysis.
Laboratory Procedures
All laboratory assessments were obtained at baseline, 3, 6,
and 9 months using standardized protocols.
Height and weight
Height and weight were obtained after a 12 hour fast
between the hours of 6 am and 10 am. Height was
obtained using a stadiometer and weight was obtained
with a calibrated scale accurate to + 0.1 kg. Participants
were measured in a standard hospital gown after attempt-
ing to void.
Body composition and regional adiposity
DEXA (Lunar Corp.) was used to determine, total fat
mass, trunk fat mass, fat free mass, and percent body fat.
Women received a pregnancy test prior to each DEXA test.
The DEXA was calibrated daily using the calibration block
supplied by the manufacturer and weekly using a spine
phantom, and each site utilized a single operator. A drift
of more than 3% was established a priori as the action
level requiring instrument service and recalibration; how-
ever, this action was not required during the study. Appli-
cation software provided by the manufacturer was utilized
to quantitate body composition. As a surrogate measure
of abdominal adiposity, waist circumference was meas-
ured using the procedures of Lohman et al. [29].
Metabolic profile
Blood samples were obtained after a 12 hour fast. Serum
cholesterol and triglyceride concentrations were measured
by the hospital clinical laboratories at each site using an
automated analyzer (Du Pont Co), and using standard
enzymatic techniques. High-density lipoproteins (HDL)
were measured after removal of very-low-density lipopro-
teins (VLDL) and low-density lipoproteins (LDL) from
samples by precipitation with phosphotungstate [30].
Glucose was measured using an autoanalyzer (Beckman)
and insulin was measured using a double-label antibody
technique [31]. Calcitonin (Immutopics, San Clemente,
CA), 25-OH-D and 1,25-(OH)2-D (Alpco Diagnostics,
Windham, NH) levels were measured via immunoassay
using commercial kits.
Blood pressure
Blood pressure was measured using a sphygmomanome-
ter with the subject seated for a minimum of 5 minutes in
an isolated room with the arm bared, supported, and
positioned at the heart level. A cuff was selected based on
measurement of the length and circumference of the arm
[32]. Systolic (SBP) and diastolic pressures (DBP) were
recorded [32]. Two measures were averaged and addi-
tional measures were obtained if the measures differed by
more than 5 mm Hg [34,35].
Resting metabolic rate (RMR) and respiratory quotient (RQ)
RMR was determined by indirect calorimetry using the
open circuit technique between the hours of 6 am and 10
am after a 12 hour fast and 48 hour abstention from exer-
cise [36]. The participant rested quietly for 30 minutes inNutrition & Metabolism 2008, 5:28 http://www.nutritionandmetabolism.com/content/5/1/28
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an isolated room with the temperature controlled to 21–
24 degrees centigrade. Subsequently, the participant was
placed in a ventilated hood for a minimum of 30 minutes.
Criteria for a valid metabolic rate was a minimum of 15
minutes of steady state with steady state determined as
less than 10% fluctuation in minute ventilation and oxy-
gen consumption and less than 5% fluctuation in respira-
tory quotient (Sensormedics Corporation, Yorba Linda,
CA). Metabolic rate was calculated using the Weir equa-
tions [37]. RQ was calculated as carbon dioxide produc-
tion/oxygen consumption [38].
Statistics and Data Analysis
Descriptive statistics for all variables were calculated for
the entire study population and also calculated by treat-
ment group at all four time points. Frequencies and per-
centages were used to summarize categorical variables and
means and standard deviations were used to summarize
quantitative variables.
The primary method of analysis was linear mixed models
and the primary outcomes were change from the start of
the maintenance period (3 months) to the midpoint (6
months) and end (9 months) of maintenance periods (i.e.
6 months value – 3 months value and 9 months value – 3
months value). The models had a mean structure consist-
ing of an intercept and the following variables: baseline
(time 0) value, time period (6 months, 9 months), treat-
ment group (recommended dairy, low dairy), site (UT,
KU), and an interaction of treatment group by site. Inter-
action between treatment group and time period was
tested but was not significant in any of the models so it
was not used.
The covariance structure used for the models was com-
pound symmetric and its parameters were allowed to dif-
fer for the two treatment groups. The p-values shown in
the tables for "Type III Tests of Fixed Effects" are from F-
tests against the null hypothesis that the parameter value
for each variable is zero given that all other variables and
the interaction are in the model. Kenward-Roger adjust-
ments for the denominator degrees of freedom were used
in all models. Due to the significant site by treatment
group interaction in the models, post-hoc Tukey adjusted
t-tests for pair-wise comparisons of interest were calcu-
lated when the overall tests were significant. A separate
model was run for each variable.
Differences within treatment groups in the mean change
in weight, RMR, RQ, BMI, total body fat, trunk fat and
waist circumference between baseline and 3 months was
tested via a Satterthwaite adjusted two sample t-test. The
same type of test was used for testing differences in die-
tary/energy intake variables between treatment groups at
each of the four time periods. All analyses were done
using SAS version 9.1 (SAS Institute Inc., Cary, NC, USA).
Registration: ClinicalTrials.gov NCT00686426
Results
Participants
Three hundred thirty eight participants were randomized
at baseline and 270 (82%) were eligible for evaluation
during maintenance. Of those not eligible for evaluation,
46 did not meet the weight loss requirements. Seventy
nine percent of participants were Caucasian, 15% His-
panic, 5% African American, and 1% Other. No signifi-
cant differences at baseline existed for participants in the
recommended or low dairy groups (Table 2), and there
were no differences between the dropouts and those
remaining in the study. However, there were site differ-
ences in baseline weight and adiposity among those sub-
jects who were subsequently eligible to enter the weight
maintenance phase (Table 3). The UT site exhibited a
lower body weight (97.1 vs. 102.2 kg, p = 0.0012) and fat
(43.9 vs. 46.7%, p = 0.0021) compared to the KU site.
Table 2: Baseline characteristics by group (month 0)
LD RD
Age (years) 40.7 ± 6.8 39.9 ± 7.2
Weight (kg) 99.5 ± 12.9 101.1 ± 12.8
BMI (kg/m2) 34.6 ± 3.1 34.4 ± 3.2
Body Fat (%) 45.9 ± 7.4 45.4 ± 7.2
Waist Circumference (cm) 101.6 ± 9.2 102.7 ± 9.6
Systolic Blood Pressure (mmHg) 125.2 ± 13.0 125.4 ± 12.8
Diastolic Blood Pressure (mmHg) 82.1 ± 8.5 83.2 ± 9.1
Total Cholesterol (mg/dl) 201.3 ± 37.1 202.7 ± 35.1
HDL-Cholesterol (mg/dl) 52.7 ± 14.3 50.2 ± 12.3
LDL-Cholesterol (mg/dl) 118.5 ± 30.6 121.4 ± 31.4
Triglycerides (mg/dl) 150.5 ± 88.6 154.1 ± 88.3
Glucose (mg/dl) 94.0 ± 20.1 92.1 ± 8.8
Insulin (mcgIU/ml) 10.6 ± 7.2 10.3 ± 5.0
Values are means ± standard deviation. LD = low dairy; RD = 
recommended dairy. There were no significant differences between 
groups for any variable.Nutrition & Metabolism 2008, 5:28 http://www.nutritionandmetabolism.com/content/5/1/28
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Energy intake during weight loss and maintenance
Reported energy intake during weight loss was 1258 ± 202
kcal/d for the recommended dairy group and 1199 ± 187
kcal/d for the low dairy group (p = 0.01). Reported energy
intake during weight maintenance at 6 months was 9%
below study baseline values for the recommended dairy
group and 22% below baseline values for the low dairy
group. Reported energy intake during weight mainte-
nance at 9 months remained 9% below baseline values for
the recommended dairy group and was 19% below base-
line values for the low dairy group. Energy intake was sig-
nificantly greater (p < 0.0001) for the recommended dairy
group compared to the low dairy group during weight
maintenance (Figure 2). There were significant site differ-
ences in energy intake at each measured time point, with
participants at the UT site consistently reporting ~100 kcal
less/day than those at the KU site (Table 4); however, the
aforementioned observed difference between energy
intake in the recommended dairy group compared to the
low dairy group was consistent across the two sites.
Dairy and calcium intake during weight loss and 
maintenance
During weight loss, the recommended dairy group con-
sumed 1.2 ± 0.5 servings of dairy/d and low dairy con-
sumed 1.1 ± 0.5 servings of dairy/d (NS). From 3 to 6
months, recommended dairy consumed 3.0 ± 0.6 servings
of dairy/d and low dairy consumed 0.6 ± 0.3 servings of
dairy/d (p < 0.0001). From 6 to 9 months, recommended
dairy consumed 3.1 ± 0.5 servings of dairy/d and low
dairy consumed 0.7 ± 0.4 servings of dairy/d (p < 0.0001).
During weight loss, calcium intake was 731 ± 251 mg/d
for the recommended dairy group compared to 707 ± 230
mg/d for the low dairy group (NS). During weight main-
tenance, calcium intake was 1325 ± 254 mg/d for the rec-
ommended dairy group compared to 579 ± 166 mg/d for
the low dairy group (p < 0.0001).
Physical activity (steps)
PA was nearly identical for recommended and low dairy
groups. The recommended level of dairy group at 3, 6, and
Table 3: Measurements for all subjects who were eligible for weight maintenance by site at baseline (month 0)
Baseline (Month 0) P-value for site difference
KU (n = 163) UT (n = 107)
Age (years) 40.8 ± 7.0 40.0 ± 6.7 0.2464
Weight (kg) 102.2 ± 13.2 97.1 ± 11.4 0.0012
BMI (kg/m2) 34.7 ± 3.3 33.9 ± 2.7 0.0527
Body Fat (%) 46.7 ± 7.6 43.9 ± 6.3 0.0021
Waist Circumference (cm) 101.5 ± 9.6 103.1 ± 8.9 0.1621
Systolic Blood Pressure (mmHg) 125.7 ± 13.1 123.9 ± 12.1 0.2502
Diastolic Blood Pressure (mmHg) 82.6 ± 8.8 82.5 ± 8.4 0.9255
Total Cholesterol (mg/dl) 203.1 ± 35.1 202.1 ± 37.7 0.8245
HDL-Cholesterol (mg/dl) 51.7 ± 12.9 51.9 ± 13.9 0.9324
LDL-Cholesterol (mg/dl) 120.9 ± 28.9 119.5 ± 33.9 0.7149
Triglycerides (mg/dl) 149.7 ± 83.3 153.6 ± 93.0 0.7179
Glucose (mg/dl) 92.3 ± 18.6 93.9 ± 9.0 0.4047
Insulin (mcgIU/ml) 9.6 ± 5.6 10.6 ± 3.8 0.1254
Body Fat (kg) 44.6 ± 8.7 42.5 ± 7.3 0.0442
Trunk Fat (kg) 23.3 ± 4.4 23.0 ± 4.0 0.5891
Values are means +SDNutrition & Metabolism 2008, 5:28 http://www.nutritionandmetabolism.com/content/5/1/28
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9 months had 8546 ± 2008, 8754 ± 2227, and 8765 ±
2252 steps/d, respectively. The low dairy group at 3, 6,
and 9 months had 8332 ± 2320, 8729 ± 2436, and 8789
± 2320 steps/d, respectively.
Body weight, BMI, body composition, and waist 
circumference
There were no significant differences between the recom-
mended and low dairy group for weight loss, BMI, total
body fat, trunk body fat, or waist circumference from
baseline to 3 months (Table 5). The primary outcomes of
change in weight, BMI, body fat, and trunk fat main effects
during weight maintenance showed no significant differ-
ences between the treatment groups when unadjusted for
higher level interactions. After adjusting for the treatment
group by site interaction the low dairy group at UT had
significantly greater gains in weight, BMI, and trunk fat
than the recommended dairy group at UT, and the low
dairy group at UT had significantly greater gains in weight,
BMI, total body fat, and trunk fat than the low dairy group
at KU. Differences in the recommended dairy groups
between sites were not significant, nor were differences
between the recommended dairy group and low dairy
group at KU. The recommended dairy groups at both sites
and the low dairy group at KU exhibited weight mainte-
nance from 4 to 9 months (Figure 3).
Metabolic profile
There were no significant differences between recom-
mended and low dairy groups for changes in total choles-
terol, triglycerides, HDL, LDL, SBP, DBP, glucose, and
insulin. Both the recommended and low dairy groups
showed significant increases during maintenance for cho-
lesterol (p = 0.0001), HDL (p = 0.02), LDL (p = 0.0009),
SBP (p = 0.02), and DBP (p = 0.006). Differences for trig-
lycerides, glucose, and insulin were not significant (Table
6). There were no significant differences between recom-
mended and low dairy groups during weight loss and
maintenance for changes in 25-OH-D or calcitonin. How-
ever, during maintenance, the recommended dairy group
exhibited a significant diet-induced suppression of 1,25-
(OH)2-D. Baseline 1, 25-(OH)2-D was 43.8+9.8 pg/mL in
the recommended dairy group and decreased by 5.8 and
6.9 pg/mL at 6 and 9 months, respectively (p < 0.0001),
while there was no significant change in the low dairy
group.
Resting metabolic rate and respiratory quotient (RQ)
RMR declined significantly during energy restriction from
baseline to 3 months for both recommended and low
dairy groups (p < 0.0001). RMR showed a trend (p = 0.08)
for greater increase during weight maintenance for the rec-
ommended compared to low dairy group. RQ decreased
for both recommended and low dairy groups during
energy restriction (p = 0.0007). During weight mainte-
nance, the low dairy group showed a significantly greater
increase (p < 0.01) in RQ compared to the recommended
dairy group (Table 7).
Discussion
Although recommended levels of dairy have been shown
to augment weight loss during energy restriction when
compared to low dairy intakes, little is known about the
effects of recommended levels of dairy during weight
maintenance. We investigated the effects of recom-
mended levels of dairy compared to low levels of dairy
Daily energy intake by group and time Figure 2
Daily energy intake by group and time. Values are 
means ± standard deviation. * Significant between group dif-
ferences (p < 0.05).
Table 4: Energy intake for all subjects who were eligible for weight maintenance by site and time
Maintenance baseline (3 Months)1 6 Months2 9 Months3
KU (n = 163) UT (n = 107) KU (n = 129) UT (n = 107) KU (n = 136) UT (n = 107)
Energy Intake (Kcals) 1260.1 ± 201.5 1168.2 ± 169.8 1786.2 ± 427.6 1668.6 ± 248.5 1820.1 ± 459.7 1723.7 ± 285.8
1Site difference: p < 0.0001
2Site difference: p = 0.0051
3Site difference: p = 0.0330
Values are means + SDNutrition & Metabolism 2008, 5:28 http://www.nutritionandmetabolism.com/content/5/1/28
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across 6 months of weight maintenance but found no dif-
ferences between groups for body weight or components
of body composition.
The premise of this investigation was that correction of
dietary calcium and dairy insufficiency may attenuate
weight regain following successful weight loss. Accord-
ingly, it was important to have a clear comparison of inad-
equate versus adequate levels of intake, as
supplementation of an adequate or nearly adequate diet
would be predicted to exert little or no effect. For example,
previous studies of the effects of dairy on adiposity during
energy restriction demonstrated significant effects when
the un-supplemented group had calcium and dairy food
intakes of <600 mg and <1 serving/d, respectively [5-7],
while increasing the dairy intake of a group consuming a
more moderate level of calcium (~800 mg/d) during com-
parable energy restriction exerted no effect [8]. Conse-
quently, this study was designed to distinguish between
clearly inadequate levels of calcium (<600 mg/day) and
dairy (<1 serving/day) with clearly adequate levels
(>1,000 mg calcium and >3 dairy servings/d), and our die-
tary intake data demonstrate that these parameters were
met.
The adherence to treatment during weight maintenance
was excellent, with the recommended dairy group show-
ing ~3 fold greater dairy intake compared to the low dairy
group. This was reflected in a significant decrease in 1,25-
(OH)2-D levels in the recommended dairy group, while
no change was seen in the low dairy group. Attrition was
17.4% in the recommended dairy group compared to
14.3% in the low dairy group indicating that higher levels
of dairy were well tolerated. Metabolic profile was not dif-
ferent between the recommended compared to the low
dairy group indicating that increased consumption of
dairy products did not have a negative impact on the met-
abolic profile.
Of interest, the low dairy group had decreased energy
intake compared to the recommend dairy group at all
time points yet maintenance of body weight and fat were
Anthropometric changes by group and site Figure 3
Anthropometric changes by group and site. Values are mean changes. KU, University of Kansas; UT, University of Ten-
nessee; BMI, body mass index; LD = low dairy; RD = recommended dairy. * Significant between group differences for the UT 
site during weight maintenance (p < 0.05). † Significant between site differences during weight maintenance in the LD groups (p 
< 0.05).Nutrition & Metabolism 2008, 5:28 http://www.nutritionandmetabolism.com/content/5/1/28
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not different. This suggests that diets with recommended
levels of dairy may be higher in energy content while pro-
ducing similar effects on body weight and fat as diets low
in dairy. The reason for this is unclear; however, the rec-
ommended level of dairy group had a trend towards
greater RMR during weight maintenance compared to the
low dairy group (p = 0.08) and a significantly lower RQ (p
= 0.01), indicating greater fat oxidation. Greater RMR may
impact energy balance by allowing a greater energy intake
for the recommended dairy group without increased
weight gain when compared to the low dairy group. Addi-
tionally, the recommended dairy group also may have
benefited from increased fat oxidation compared to the
low dairy group, and this also may have influenced energy
balance.
In support of this, calcitriol inhibits lipolysis and fat oxi-
dation [19], and suppressing circulating calcitriol by
increasing dairy food intake as observed in the present
study has been reported to result in increased lipolysis in
both mice [3,4,23] and humans [6,7]. Moreover, Gunther
et al [39] recently demonstrated that chronic consump-
tion (one-year) of a dairy-rich high calcium diet resulted
in a significant (~two-fold) increase in post-prandial fat
oxidation following a liquid meal challenge compared to
subjects maintained on a low-calcium diet. Further, in a
randomized controlled crossover study testing the effects
of low- and high-dairy diets on substrate oxidation whole-
room calorimetry Melanson et al [40] demonstrated that
feeding a high dairy diet under energy deficit conditions
resulted in a significant 30 g increase in 24-hour fat oxida-
tion compared to the low dairy diet. This increase in fat
oxidation represents an additional 270 kcal/day, a value
in the same range as the increase in energy intake on the
recommended dairy diet in the present study (248 kcal for
the first half of maintenance and 200 kcal for the second
half of maintenance), suggesting that an increase in self-
reported energy intake in subjects consuming the recom-
mended level of dairy may have been compensated for by
a comparable increase in fat oxidation. These values also
are consistent with data from Harvey-Berino et al [16].
Table 5: Reductions in anthropometric measures during weight 
loss by group (months 0–3)
L D RD
Weight (kg) 11.2 ± 3.3 11.2 ± 3.8
BMI (kg/m2) 3.9 ± 1.1 3.8 ± 1.3
Body Fat (%) 4.6 ± 2.9 4.1 ± 3.0
Body Fat (kg) 8.5 ± 3.2 8.2 ± 3.2
Trunk Fat (kg) 4.7 ± 2.1 4.8 ± 2.1
Lean mass (kg) 2.7 ± 2.1 3.0 ± 2.3
Waist Circumference (cm) 7.9 ± 3.3 7.5 ± 4.3
Values are means ± standard deviation. LD = low dairy, RD = 
recommended dairy. There were no significant differences between 
groups for any variable.
Table 6: Changes in blood pressure and bood chemistry by treatment group over time
Baseline 3 Month 9 Month
LD RD LD RD LD RD
SBP 125.2 ± 13.0 125.4 ± 12.8 117.4 ± 9.8 116.7 ± 11.3 118.8 ± 10.8* 116.9 ± 10.4*
DBP 82.1 ± 8.5 83.2 ± 9.1 77.4 ± 8.4 77.6 ± 7.8 78.4 ± 8.7* 77.9 ± 8.2*
Cholesterol 201.3 ± 37.1 202.7 ± 35.1 170.1 ± 32.5 176.0 ± 36.4 191.7 ± 34.5* 195.9 ± 34.4*
HDL 52.7 ± 14.3 50.2 ± 12.3 47.3 ± 11.2 46.8 ± 9.9 54.1 ± 12.6* 53.9 ± 12.4*
LDL 118.5 ± 30.6 121.4 ± 31.4 101.2 ± 26.7 106.6 ± 30.7 113.5 ± 30.8* 116.7 ± 32.2*
Triglycerides 150.5 ± 88.6 154.1 ± 88.3 106.1 ± 47.6 111.7 ± 47.6 119.1 ± 53.2 123.0 ± 59.2
Glucose 94.0 ± 20.1 92.1 ± 8.8 88.4 ± 7.5 88.8 ± 7.7 90.8 ± 15.1 90.0 ± 8.2
Insulin 10.6 ± 7.2 10.3 ± 5.0 6.9 ± 4.0 7.2 ± 4.5 7.8 ± 4.2 7.7 ± 4.2
Values are means ± standard deviation. LD = low dairy; RD = recommended dairy. There were no significant differences in the baseline to 3 months 
changes between groups. *Significant change from 3 to 9 months within treatment group (p < 0.05). There were no significant differences in change 
from 3 to 9 months between treatment group.Nutrition & Metabolism 2008, 5:28 http://www.nutritionandmetabolism.com/content/5/1/28
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Although they reported no effect of dairy on weight or fat
loss in overweight and obese adults over a one-year period
of a prescribed 500 kcal/day deficit, their data demon-
strate that the high dairy group maintained an energy def-
icit of only 314 and 224 kcal/day at 3 and 12 months,
respectively, compared to respective deficits of 442 and
402 kcal/day in the low dairy group. Thus, the high dairy
group experienced comparable weight loss while consum-
ing an additional ~150 kcal/day. In a similar randomized
study, Thompson et al [8] reported similar weight loss in
moderate and high dairy groups prescribed a 500 kcal/day
deficit, but those consuming the high dairy diet con-
sumed significantly more energy (~150 kcal/day) while
still attaining the same weight and fat loss. Accordingly,
we suggest that greater fat oxidation in the present study
may have permitted a corresponding increase in energy
intake in subjects consuming the recommended level of
dairy intake compared to those on low dairy intakes with-
out adversely affecting body weight or body fat.
An additional consideration is the potential direct effect
of recommended vs. low levels of dairy intake on appetite
and food consumption. Dairy products have been pro-
posed to increase satiety and attenuate food intake due to
both protein-induced satiety [41,42] and to the casei-
nomacropeptide which is released during digestion of
dairy protein and stimulates cholecystokin release [43].
However, Hollis and Mattes [44] recently reported that
feeding three daily dairy servings for seven days in a rand-
omized cross-over study resulted in a significant increase
in energy consumption (209 kcal/day) compared to the
low dairy period. This number is remarkably consistent
with the increased energy consumption by the recom-
mended dairy group in both the present study and earlier
reports [8,16]. Thus, although Hollis and Mattes reported
that the additional energy provided by supplementary
dairy products is not fully compensated for by a reduction
in subsequent energy intake [44], these data suggest that
subjects consuming recommended levels of dairy operate
at a lower metabolic efficiency which may result in a shift
to greater fat oxidation compared to individuals consum-
ing low levels of dairy. Consequently, the additional
energy intake does not result in corresponding gain in
weight or fat. Moreover, Ochner and Lowe [45] recently
reported that greater calcium intake (primarily derived
from dairy sources) inversely predicted weight gain fol-
lowing weight loss by overweight and obese women only
when controlling for energy intake. Higher energy intake
significantly predicted weight regain only when control-
ling for changes in dietary calcium intake. Accordingly,
their data indicate that weight gain from excess energy
intake following weight loss is attenuated by attaining
adequate levels of dairy calcium intake.
There were significant site differences with respect to
weight change during the maintenance phase. During the
first three months of maintenance, the low dairy group at
UT exhibited weight regain that was significantly attenu-
ated in the recommended dairy group; in contrast, the KU
cohort exhibited continued weight loss during the first
three months of the maintenance phase. Both patterns are
common in studies of regain, with some extending adher-
ence to behavioral strategies learned during weight loss
into the early ad libitum dietary phase while others dem-
onstrate rapid regain, although longer term studies con-
sistently demonstrate regain within 12 months. Although
consistent methodology was used across the two sites, it
appears that there were site differences in the retention of
the behavioral strategies acquired by subjects during the
weight loss phase. Nonetheless, the effects of recom-
mended dairy intakes on fat oxidation as evidenced by RQ
changes and on the ability to consume more food energy
than low dairy consumers without adversely affecting
body weight or body composition was consistent across
the two sites in both separate and combined analyses.
This study was conducted in free-living outpatients, with
attendant limitations of adherence to protocol and under-
reporting of energy intake. Nonetheless, key strengths of
this investigation include its sample size (n = 338
enrolled, 270 completed) and adherence to diet, the latter
of which is supported by confirmation of anticipated sup-
pression of 1,25-(OH)2-D in the recommended dairy
group during the maintenance phase.
Table 7: Changes in Resting Metabolic Rate (RMR) and Respiratory Quotient (RQ) by group
Baseline 3 Month 9 Month
LD RD LD RD LD RD
RMR* 1881 ± 320 1901 ± 344 1689 ± 301 1701 ± 304 1751 ± 340 1831 ± 343
RQ*† 0.77 ± 0.06 0.76 ± 0.05 0.74 ± 0.04 0.74 ± 0.05 0.77 ± 0.05 0.76 ± 0.06
Values are means ± standard deviation. LD = low dairy; RD = recommended dairy. *Significant change from baseline to 3 months (p < 0.0001). 
†Significant difference in the change between 3 to 9 months between groups (p < 0.01).Nutrition & Metabolism 2008, 5:28 http://www.nutritionandmetabolism.com/content/5/1/28
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Conclusion
Fifty percent of adults attempt to lose and maintain
weight loss annually. Individuals frequently utilize diets
that restrict nutrients and eliminate food groups in the
effort to achieve weight loss and maintenance, and dairy
products are often viewed as potentially fattening by
many who diet, especially women. This investigation
could find no disadvantage for weight maintenance by
consuming a diet with the recommended levels of dairy
products compared to a low level of dairy products. Those
who did consume the recommended amount of dairy
products during weight maintenance exhibited evidence
of greater fat oxidation and were able to consume a greater
amount of total energy compared to those who consumed
less dairy products without any additional weight gain.
Being able to consume greater amounts of energy may
provide benefit for chronic adherence to a weight mainte-
nance diet. This study indicates that dairy products may be
used in a weight maintenance diet without contributing to
weight gain compared to diets that are low in dairy prod-
ucts.
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